Phase II studies in soft tissue sarcoma: time for reappraisal.
about
Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma.Primary Angiosarcoma of the Spleen: Rare Diagnosis with Atypical Clinical CourseCutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan.
P2860
Phase II studies in soft tissue sarcoma: time for reappraisal.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Phase II studies in soft tissue sarcoma: time for reappraisal.
@ast
Phase II studies in soft tissue sarcoma: time for reappraisal.
@en
Phase II studies in soft tissue sarcoma: time for reappraisal.
@nl
type
label
Phase II studies in soft tissue sarcoma: time for reappraisal.
@ast
Phase II studies in soft tissue sarcoma: time for reappraisal.
@en
Phase II studies in soft tissue sarcoma: time for reappraisal.
@nl
prefLabel
Phase II studies in soft tissue sarcoma: time for reappraisal.
@ast
Phase II studies in soft tissue sarcoma: time for reappraisal.
@en
Phase II studies in soft tissue sarcoma: time for reappraisal.
@nl
P2860
P1433
P1476
Phase II studies in soft tissue sarcoma: time for reappraisal.
@en
P2093
Stefan Sleijfer
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0382
P577
2012-01-27T00:00:00Z